Fabrizio Pane

25PUBLICATIONS
151CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Oct 08, 2026
Roginolisib in Combination with JAK Inhibitors in Patients with Myelofibrosis Who are Unresponsive to Approved JAK Inhibitors (Study HEMA-MED) - A Trial in Progress.

|Mar 28, 2026
Early Ibrutinib Dose Modifications in CLL: A Post Hoc Analysis of the Real-World EVIdeNCE Study.

Stefano Molica, Potito Rosario Scalzulli, Lydia Scarfò

|Mar 26, 2026
Recurrent cytokine release syndrome in patients receiving bispecific antibody therapy for multiple myeloma: a case series.

Roberta Della Pepa, Aldo Leone, Francesco Grimaldi

|Oct 16, 2025
Routine Imaging Surveillance After Frontline ABVD Improves Outcome in High-Risk Hodgkin Lymphoma.

Novella Pugliese, Marco Picardi, Annamaria Vincenzi

|Sep 05, 2025
Impact of Dara-VTD induction therapy on stem cell mobilization outcomes in newly diagnosed multiple myeloma patients undergoing autologous stem cell transplantation: a multicenter study.

Roberta Della Pepa, Salvatore Palmieri, Stefano Rocco

|Aug 08, 2025
Treatment-Free Remission in Chronic Phase Chronic Myeloid Leukemia After Nilotinib De-Escalation: 96-Week Update of the DANTE Study.

Alessandra Iurlo, Massimo Breccia, Fabio Stagno

Pageof 5

Frequent Collaborators

10 joint publications

Novella Pugliese

9 joint publications

Roberta Della Pepa

6 joint publications

Marco Picardi

5 joint publications

Claudia Giordano